La maladie de Parkinson en France (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Chronic subthalamic nucleus stimulation and striatal D2 dopamine receptors in Parkinson's disease--A [(11)C]-raclopride PET study.

Identifieur interne : 001035 ( PubMed/Curation ); précédent : 001034; suivant : 001036

Chronic subthalamic nucleus stimulation and striatal D2 dopamine receptors in Parkinson's disease--A [(11)C]-raclopride PET study.

Auteurs : S. Thobois [France] ; V. Fraix ; M. Savasta ; N. Costes ; P. Pollak ; P. Mertens ; A. Koudsie ; D. Le Bars ; A L Benabid ; E. Broussolle

Source :

RBID : pubmed:14586606

English descriptors

Abstract

Subthalamic nucleus (STN) stimulation mechanism of action remains a matter for debate. In animals, an increased striatal dopamine (DA) release due to STN stimulation has been reported.

DOI: 10.1007/s00415-003-0188-z
PubMed: 14586606

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:14586606

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Chronic subthalamic nucleus stimulation and striatal D2 dopamine receptors in Parkinson's disease--A [(11)C]-raclopride PET study.</title>
<author>
<name sortKey="Thobois, S" sort="Thobois, S" uniqKey="Thobois S" first="S" last="Thobois">S. Thobois</name>
<affiliation wicri:level="1">
<nlm:affiliation>Dept. of Neurology D (Pr. G. Chazot) and INSERM U 534, Hôpital Neurologique Pierre Wertheimer, 59 Bd Pinel, 69003 Lyon, France. stephane.thobois@chu-lyon.fr</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Dept. of Neurology D (Pr. G. Chazot) and INSERM U 534, Hôpital Neurologique Pierre Wertheimer, 59 Bd Pinel, 69003 Lyon</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Fraix, V" sort="Fraix, V" uniqKey="Fraix V" first="V" last="Fraix">V. Fraix</name>
</author>
<author>
<name sortKey="Savasta, M" sort="Savasta, M" uniqKey="Savasta M" first="M" last="Savasta">M. Savasta</name>
</author>
<author>
<name sortKey="Costes, N" sort="Costes, N" uniqKey="Costes N" first="N" last="Costes">N. Costes</name>
</author>
<author>
<name sortKey="Pollak, P" sort="Pollak, P" uniqKey="Pollak P" first="P" last="Pollak">P. Pollak</name>
</author>
<author>
<name sortKey="Mertens, P" sort="Mertens, P" uniqKey="Mertens P" first="P" last="Mertens">P. Mertens</name>
</author>
<author>
<name sortKey="Koudsie, A" sort="Koudsie, A" uniqKey="Koudsie A" first="A" last="Koudsie">A. Koudsie</name>
</author>
<author>
<name sortKey="Le Bars, D" sort="Le Bars, D" uniqKey="Le Bars D" first="D" last="Le Bars">D. Le Bars</name>
</author>
<author>
<name sortKey="Benabid, A L" sort="Benabid, A L" uniqKey="Benabid A" first="A L" last="Benabid">A L Benabid</name>
</author>
<author>
<name sortKey="Broussolle, E" sort="Broussolle, E" uniqKey="Broussolle E" first="E" last="Broussolle">E. Broussolle</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2003">2003</date>
<idno type="RBID">pubmed:14586606</idno>
<idno type="pmid">14586606</idno>
<idno type="doi">10.1007/s00415-003-0188-z</idno>
<idno type="wicri:Area/PubMed/Corpus">001076</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001076</idno>
<idno type="wicri:Area/PubMed/Curation">001035</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001035</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Chronic subthalamic nucleus stimulation and striatal D2 dopamine receptors in Parkinson's disease--A [(11)C]-raclopride PET study.</title>
<author>
<name sortKey="Thobois, S" sort="Thobois, S" uniqKey="Thobois S" first="S" last="Thobois">S. Thobois</name>
<affiliation wicri:level="1">
<nlm:affiliation>Dept. of Neurology D (Pr. G. Chazot) and INSERM U 534, Hôpital Neurologique Pierre Wertheimer, 59 Bd Pinel, 69003 Lyon, France. stephane.thobois@chu-lyon.fr</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Dept. of Neurology D (Pr. G. Chazot) and INSERM U 534, Hôpital Neurologique Pierre Wertheimer, 59 Bd Pinel, 69003 Lyon</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Fraix, V" sort="Fraix, V" uniqKey="Fraix V" first="V" last="Fraix">V. Fraix</name>
</author>
<author>
<name sortKey="Savasta, M" sort="Savasta, M" uniqKey="Savasta M" first="M" last="Savasta">M. Savasta</name>
</author>
<author>
<name sortKey="Costes, N" sort="Costes, N" uniqKey="Costes N" first="N" last="Costes">N. Costes</name>
</author>
<author>
<name sortKey="Pollak, P" sort="Pollak, P" uniqKey="Pollak P" first="P" last="Pollak">P. Pollak</name>
</author>
<author>
<name sortKey="Mertens, P" sort="Mertens, P" uniqKey="Mertens P" first="P" last="Mertens">P. Mertens</name>
</author>
<author>
<name sortKey="Koudsie, A" sort="Koudsie, A" uniqKey="Koudsie A" first="A" last="Koudsie">A. Koudsie</name>
</author>
<author>
<name sortKey="Le Bars, D" sort="Le Bars, D" uniqKey="Le Bars D" first="D" last="Le Bars">D. Le Bars</name>
</author>
<author>
<name sortKey="Benabid, A L" sort="Benabid, A L" uniqKey="Benabid A" first="A L" last="Benabid">A L Benabid</name>
</author>
<author>
<name sortKey="Broussolle, E" sort="Broussolle, E" uniqKey="Broussolle E" first="E" last="Broussolle">E. Broussolle</name>
</author>
</analytic>
<series>
<title level="j">Journal of neurology</title>
<idno type="ISSN">0340-5354</idno>
<imprint>
<date when="2003" type="published">2003</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adult</term>
<term>Aged</term>
<term>Carbon Radioisotopes</term>
<term>Dopamine (secretion)</term>
<term>Dopamine Antagonists</term>
<term>Electric Stimulation Therapy</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Parkinson Disease (diagnostic imaging)</term>
<term>Parkinson Disease (therapy)</term>
<term>Raclopride</term>
<term>Receptors, Dopamine D2 (physiology)</term>
<term>Subthalamic Nucleus (physiology)</term>
<term>Tomography, Emission-Computed</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="physiology" xml:lang="en">
<term>Receptors, Dopamine D2</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="secretion" xml:lang="en">
<term>Dopamine</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en">
<term>Carbon Radioisotopes</term>
<term>Dopamine Antagonists</term>
<term>Raclopride</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic imaging" xml:lang="en">
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en">
<term>Subthalamic Nucleus</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en">
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adult</term>
<term>Aged</term>
<term>Electric Stimulation Therapy</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Tomography, Emission-Computed</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Subthalamic nucleus (STN) stimulation mechanism of action remains a matter for debate. In animals, an increased striatal dopamine (DA) release due to STN stimulation has been reported.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">14586606</PMID>
<DateCreated>
<Year>2003</Year>
<Month>10</Month>
<Day>30</Day>
</DateCreated>
<DateCompleted>
<Year>2003</Year>
<Month>12</Month>
<Day>12</Day>
</DateCompleted>
<DateRevised>
<Year>2016</Year>
<Month>11</Month>
<Day>24</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0340-5354</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>250</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2003</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Journal of neurology</Title>
<ISOAbbreviation>J. Neurol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Chronic subthalamic nucleus stimulation and striatal D2 dopamine receptors in Parkinson's disease--A [(11)C]-raclopride PET study.</ArticleTitle>
<Pagination>
<MedlinePgn>1219-23</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText Label="CONTEXT" NlmCategory="BACKGROUND">Subthalamic nucleus (STN) stimulation mechanism of action remains a matter for debate. In animals, an increased striatal dopamine (DA) release due to STN stimulation has been reported.</AbstractText>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To determine in Parkinson's disease (PD) patients using positron emission tomography (PET) and [11C]-Raclopride, whether STN stimulation induces a striatal DA release.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Nine PD patients with bilateral STN stimulation were enrolled and underwent two [11C]-Raclopride PET scans. The scans were randomly performed in off and on stimulation conditions. Striatal [11C]-Raclopride binding potential (BP) was calculated using regions of interest and statistical parametric mapping.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">For PD patients, the mean [(11C]-Raclopride BP (+/- SD) were, in Off stimulation condition: 1.7 +/- 0.3 for the right caudate nucleus, 1.8 +/- 0.4 for the left caudate nucleus, 2.6 +/- 0.5 for the right putamenand 2.6 +/- 0.5 for the left putamen. In On stimulation condition: 1.7 +/- 0.4 for the right caudate nucleus, 1.9 +/- 0.5 for the left caudate nucleus, 2.8 +/- 0.7 for the right putamen and 2.7 +/- 0.8 for the left putamen. No significant difference of BP related to the stimulation was noted.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">STN stimulation does not produce significant variations of striatal DA release as assessed by PET and [11C]-Raclopride.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Thobois</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Dept. of Neurology D (Pr. G. Chazot) and INSERM U 534, Hôpital Neurologique Pierre Wertheimer, 59 Bd Pinel, 69003 Lyon, France. stephane.thobois@chu-lyon.fr</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fraix</LastName>
<ForeName>V</ForeName>
<Initials>V</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Savasta</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Costes</LastName>
<ForeName>N</ForeName>
<Initials>N</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Pollak</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Mertens</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Koudsie</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Le Bars</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Benabid</LastName>
<ForeName>A L</ForeName>
<Initials>AL</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Broussolle</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016430">Clinical Trial</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>J Neurol</MedlineTA>
<NlmUniqueID>0423161</NlmUniqueID>
<ISSNLinking>0340-5354</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D002250">Carbon Radioisotopes</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018492">Dopamine Antagonists</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D017448">Receptors, Dopamine D2</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>430K3SOZ7G</RegistryNumber>
<NameOfSubstance UI="D020891">Raclopride</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>VTD58H1Z2X</RegistryNumber>
<NameOfSubstance UI="D004298">Dopamine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002250" MajorTopicYN="N">Carbon Radioisotopes</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004298" MajorTopicYN="N">Dopamine</DescriptorName>
<QualifierName UI="Q000557" MajorTopicYN="Y">secretion</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018492" MajorTopicYN="Y">Dopamine Antagonists</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004599" MajorTopicYN="Y">Electric Stimulation Therapy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName>
<QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D020891" MajorTopicYN="Y">Raclopride</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D017448" MajorTopicYN="N">Receptors, Dopamine D2</DescriptorName>
<QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D020531" MajorTopicYN="N">Subthalamic Nucleus</DescriptorName>
<QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014055" MajorTopicYN="N">Tomography, Emission-Computed</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2003</Year>
<Month>01</Month>
<Day>24</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2003</Year>
<Month>05</Month>
<Day>27</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2003</Year>
<Month>06</Month>
<Day>02</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2003</Year>
<Month>10</Month>
<Day>31</Day>
<Hour>5</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2003</Year>
<Month>12</Month>
<Day>13</Day>
<Hour>5</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2003</Year>
<Month>10</Month>
<Day>31</Day>
<Hour>5</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">14586606</ArticleId>
<ArticleId IdType="doi">10.1007/s00415-003-0188-z</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001035 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 001035 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:14586606
   |texte=   Chronic subthalamic nucleus stimulation and striatal D2 dopamine receptors in Parkinson's disease--A [(11)C]-raclopride PET study.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:14586606" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a ParkinsonFranceV1 

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024